← Open Payments lookup

IRINA ASHAMALLA: Open Payments

NPI 1205365772 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$508 in 17 payments from 10 companies in 2025. Trend: 2023 $1,526 · 2024 $75 · 2025 $508

Food & beverage: $508
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.6$268
Janssen Pharmaceuticals, Inc2$51
ABBVIE INC.2$41
Alkermes, Inc.1$29
E.R. Squibb & Sons, L.L.C.1$25
Bausch Health US, LLC1$25
Supernus Pharmaceuticals, Inc.1$19
Axsome Therapeutics, Inc.1$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16
Lilly USA, LLC1$15

Products named: FANAPT, SPRAVATO, VRAYLAR, ARISTADA, COBENFY, APLENZIN, Qelbree, Auvelity.

Industry payments across AZ — which companies pay providers there.